How do brands' "own generics" affect pharmaceutical prices?

Review of Industrial Organization

Volumn 27, Issue 4, 2005, Pages 329-350

  Hollis, Aidan ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Competition; Generics; Pharmaceuticals

Indexed keywords

PHARMACEUTICAL INDUSTRY; PRICE DYNAMICS;

EID: 31144443042     PISSN: 0889938X     EISSN: 15737160     Source Type: Journal    
DOI: 10.1007/s11151-005-5469-5     Document Type: Article

References (22)

1. A.H. Anis 1992 'Pharmaceutical Prices with Insurance Coverage and Formularies' Canadian Journal of Economics 25 420-437
2. A.H. Anis D.P. Guh J.W. Woolcott 2003 'Lowering Generic Drug Prices: Less Regulation Equals More Competition' Medical Care 41 1 135-141 10.1097/00005650-200301000-00015
3. T. Aronsson M. Bergman N. Rudholm 2001 'The Impact of Generic Drug Competition on Brand Name Market Shares - Evidence from Micro Data' Review of Industrial Organization 19 4 425-435 10.1023/A:1012504310953
4. J.P. Bae 1997 'Drug Patent Expirations and the Speed of Generic Entry' Health Services Research 32 1 87-101
5. S. Bound R. JaegerD.A. Baker 1995 'Problems with Instrumental Variables Estimation when the Correlation between the Instruments and the Endogenous Explanatory Variable is Weak' Journal of the American Statistical Association 90 443-450
6. R. Caves M. Whinston M. Hurwitz 1991 'Patent Expiration, Entry, and Competition in the U.S. Pharmaceutical Industry' Brookings Papers: Microeconomics 1991 1-48
7. J.M. Ferrandiz 1999 'The Impact of Generic Goods in the Pharmaceutical Industry' Health Economics 8 599-612
8. J.M. Ganther D.H. Kreling 2000 'Consumer Perceptions of Risk and Required Cost Savings for Generic Prescription Drugs' Journal of the American Pharmaceutical Association 40 3 378-383
9. H. Grabowski J. Vernon 1992 'Brand Loyalty, Entry, and Price Competition in Pharmaceuticals after the 1984 Drug Act' Journal of Law and Economics 35 331-350 10.1086/467257
10. A. Hollis 2002 'The Importance of Being First: Evidence from Canadian Generic Pharmaceuticals' Health Economics 11 723-734 10.1002/hec.698
11. A. Hollis 2003 'The Anti-Competitive Effects of Brand-Controlled 'Pseudo-Generics' in the Canadian Pharmaceutical Market' Canadian Public Policy 29 1 21-31
12. T. Jambulingam D.H. Kreling 1995 'Relationship between the Number of Firms and Generic Price Competition' Journal of Research in Pharmaceutical Economics 6 3 39-60
13. J. Johnson D. Myatt 2003 'Multiproduct Quality Competition: Fighting Brands and Product Line Pruning' American Economic Review 93 3 748-774
14. M.I. Kamien I. Zang 1999 'Virtual Patent Extension by Cannibalization' Southern Economic Journal 66 117-131
15. Y. Kong 2004 'The Price Premium of Generic to Brand-Names and Pharmaceutical Price Index' Applied Economics 36 731-737 10.1080/ 0003684042000222106
16. Y Kong J. Seldon 2004 'Pseudo-Generic Products and Barriers to Entry in Pharmaceutical Markets' Review of Industrial Organization 25 71-86 10.1023/B:REIO.0000040524.32034.04
17. F.S. Morton 1999 'Entry Decisions in the Generic Pharmaceutical Industry' Rand Journal of Economics 30 3 421-440
18. F.S. Morton 2002 'Horizontal Integration between Brand and Generic Firms in the Pharmaceutical Industry' Journal of Economics and Management Strategy 11 1 135-168 10.1162/105864002317247604
19. F. Pammolli L. Magazzini L. Orsenigo 2002 'The Intensity of Competition after Patent Expiry in Pharmaceuticals: A Cross-Country Analysis' Revue d'Economie Industrielle 99 2 107-131
20. Salop S. (1985) 'Practices that (credibly) Facilitate Oligopoly Coordination', in J. Stiglitz et al., (eds.), New Developments in Market Structure. Cambridge: MIT Press, pp. 265-290.
21. D. Staiger J.H. Stock 1997 'Instrumental Variables Regression with Weak Instruments' Econometrica 6 557-586
22. D.C. Suh W.G. Manning Jr. S. Schondelmeyer R.S. Hadsall 2000 'Effect of Multiple-Source Entry on Price Competition after Patent Expiration in the Pharmaceutical Industry' Health Services Research 35 2 529-547